Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Kellstein

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Neuropharmacology|January 1, 1992
Cholecystokinin and opiate interactionsD J Mayer, D E Kellstein
Brain Research|May 21, 1990
Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatmentD E Kellstein, D J Mayer
Brain Research|February 1, 1991
Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neuronsD E Kellstein, D D Price, D J Mayer
Brain Research|September 3, 1990
Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neuronsD E Kellstein, D D Price, R L Hayes, et al.
Neuropharmacology|January 1, 1988
Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoaminesD E Kellstein, R T Malseed, M H Ossipov, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1990
Opioid inhibition of kainic acid-induced scratching: mediation by mu and sigma but not delta and kappa receptorsD E Kellstein, R C Coghill, H Frenk, et al.
Brain Research|March 6, 1992
Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulationJ Mao, R C Coghill, D E Kellstein, et al.
Journal of Clinical Pharmacology|May 11, 1999
The safety profile of nonprescription ibuprofen in multiple-dose use: a meta-analysisD E Kellstein, J A Waksman, S A Furey, et al.
Cephalalgia : an International Journal of Headache|September 22, 2000
Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging studyD E Kellstein, R B Lipton, R Geetha, et al.
Journal of Medicinal Chemistry|August 28, 1998
New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 positionJ M Janusz, P A Young, J M Ridgeway, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Neuropharmacology|January 1, 1992
Cholecystokinin and opiate interactionsD J Mayer, D E Kellstein
Brain Research|May 21, 1990
Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatmentD E Kellstein, D J Mayer
Brain Research|February 1, 1991
Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neuronsD E Kellstein, D D Price, D J Mayer
Brain Research|September 3, 1990
Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neuronsD E Kellstein, D D Price, R L Hayes, et al.
Neuropharmacology|January 1, 1988
Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoaminesD E Kellstein, R T Malseed, M H Ossipov, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1990
Opioid inhibition of kainic acid-induced scratching: mediation by mu and sigma but not delta and kappa receptorsD E Kellstein, R C Coghill, H Frenk, et al.
Brain Research|March 6, 1992
Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulationJ Mao, R C Coghill, D E Kellstein, et al.
Journal of Clinical Pharmacology|May 11, 1999
The safety profile of nonprescription ibuprofen in multiple-dose use: a meta-analysisD E Kellstein, J A Waksman, S A Furey, et al.
Cephalalgia : an International Journal of Headache|September 22, 2000
Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging studyD E Kellstein, R B Lipton, R Geetha, et al.
Journal of Medicinal Chemistry|August 28, 1998
New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 positionJ M Janusz, P A Young, J M Ridgeway, et al.
Pageof 2